These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12364876)

  • 1. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
    Singh N; Wagener MM; Gayowski T
    Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and management of latent tuberculosis in liver transplant patients.
    Jafri SM; Singal AG; Kaul D; Fontana RJ
    Liver Transpl; 2011 Mar; 17(3):306-14. PubMed ID: 21384513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is isoniazid safe for liver transplant candidates with latent tuberculosis?
    Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY
    Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW; Tran T; Bui L; Joyner JL
    Transplantation; 2007 Jun; 83(12):1557-62. PubMed ID: 17589337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
    Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
    Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprophylaxis with isoniazid in liver transplant recipients.
    Fábrega E; Sampedro B; Cabezas J; Casafont F; Mieses MÁ; Moraleja I; Crespo J; Pons-Romero F
    Liver Transpl; 2012 Sep; 18(9):1110-7. PubMed ID: 22645064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis outbreak in a junior high school in Kochi City--studies on factors relating to extent of tuberculosis infection and the efficacy of isoniazid chemoprophylaxis].
    Toyota M; Morioka S
    Kekkaku; 2001 Sep; 76(9):625-34. PubMed ID: 11676120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid toxicity in health care workers.
    Stuart RL; Wilson J; Grayson ML
    Clin Infect Dis; 1999 Apr; 28(4):895-7. PubMed ID: 10825056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in liver transplant recipients: a single Brazilian center experience.
    Clemente WT; Faria LC; Lima SS; Vilela EG; Lima AS; Velloso LF; Sanches MD; Cançado OL
    Transplantation; 2009 Feb; 87(3):397-401. PubMed ID: 19202445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in liver transplant patients.
    Meyers BR; Halpern M; Sheiner P; Mendelson MH; Neibart E; Miller C
    Transplantation; 1994 Aug; 58(3):301-6. PubMed ID: 8053051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of clinical tuberculosis in HIV-infected males with isoniazid prophylaxis.
    Alaei K; Alaei A; Mansouri D
    East Mediterr Health J; 2002 Nov; 8(6):754-7. PubMed ID: 15568452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.